Cellular sodium membrane transport and cardiovascular risk factors in non-insulin-dependent diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 45, Issue 8, 1996, Pages 961-965

  Foyle, Wendy Jane ^a   Fernandez, Maryam ^a   Denver, Elizabeth ^a   Sampson, Michael J ^a   Pinkney, Jon ^a   Yudkin, John S ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; PROTON; SODIUM ION; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CELL MEMBRANE TRANSPORT; CLINICAL ARTICLE; ERYTHROCYTE MEMBRANE; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK FACTOR; SODIUM TRANSPORT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0029815298     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90263-2     Document Type: Article

References (39)

1. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
2. Canessa M, Ardragna N, Solomon HS, et al: Increased sodium-lithium countertransport in red cells of patients with essential hypertension. N Engl J Med 302:772-776, 1980
3. Rutherford PA, Thomas TH, Wilkinson R: Increased erythrocyte sodium-lithium countertransport activity in essential hypertension is due to an increased affinity for extracellular sodium. Clin Sci 79:365-369, 1990
4. Turner ST, Rebbeck CR, Sing CF: Sodium-lithium counter-transport and probability of hypertension in caucasians 47-89 years old. Hypertension 20:841-850, 1992
5. Brearley CJ, Wood AJ, Aronson JK, et al: Evidence for an altered mode of action of the sodium-lithium countertransporter in vivo in patients with untreated essential hypertension. J Hypertens 11:147-153, 1993
6. Trevisan M, Ostrow D, Cooper R: Abnormal red blood cell ion transport and hypertension (the People's Gas Company Study). Hypertension 5:363-367, 1983
7. Trevisan M, Laurenzi M: Correlates of sodium-lithium countertransport. Findings from the Gubbio epidemiological study. Circulation 84:2011-2019, 1991
8. Strazzullo P, Cappuccio FP, Trevisan M: The relationship of erythrocyte sodium-lithium countertransport to blood pressure and metabolic abnormalities in a sample of untreated middle-aged workers. J Hypertens 11:815-822, 1993
9. Winocour PH, Thomas TH, Brown L, et al: Serum triglyceride and insulin levels are associated with erythrocyte sodium-lithium countertransport activity in normoglycaemic individuals. Clin Chim Acta 208:193-203, 1992
10. Bunker CH, Wing RR, Becker DJ, et al: Sodium-lithium countertransport activity is decreased after weight loss in healthy obese men. Metabolism 42:1052-1058, 1993
11. Corrocher R, Steinmayr M, Ruzzenente O: Elevation of red cell sodium-lithium countertransport in hyperlipidaemia. Life Sci 36:649-655, 1985
12. Engelmann B, Duhm J, Schontier UM, et al: Relations of sodium-lithium countertransport kinetics to plasma and red cell membrane phospholipid in hyperlipidaemia. Atherosclerosis 99:151-163, 1993
13. Jensen JS, Mathiesen ER, Norgaard K: Increased blood pressure and sodium-lithium countertransport activity are not inherited in diabetic nephropathy. Diabetologia 33:619-624, 1990
14. Walker JD, Tariq T, Viberti G: Sodium-lithium countertransport activity in red cells of patients with insulin dependent diabetes and nephropathy and their parents. Br Med J 301:635-638, 1990
15. Rutherford PA, Thomas TH, Carr SJ, et al: Changes in erythrocyte sodium-lithium countertransport kinetics in diabetic nephropathy. Clin Sci 82:301-307, 1992
16. Lopes De Faria J, Jones SL, MacDonald F, et al: Sodium-lithium countertransport activity and insulin resistance in normotensive IDDM patients. Diabetes 41:610-615, 1992
17. Ng LL, Dudley C, Bomford J, et al: Leucocyte intracellular pH and Na/H antiport activity in human hypertension. J Hypertens 7:471-475, 1989
18. Livne A, Balfe JW, Veitch R, et al: Increased platelet Na/H exchange rate in essential hypertension: Application of a novel test. Lancet 1:533-536, 1987
19. Johnson BA, Sowers JR, Zemel PC, et al: Increased sodium-lithium countertransport in black non-insulin dependent diabetic hypertensives. Am J Hypertens 3:563-565, 1990
20. Gall M, Rossing P, Jensen JS, et al: Red cell Na/Li countertransport in non-insulin dependent diabetics with diabetic nephropathy. Kidney Int 39:135-140, 1991
21. Pinkney JH, Foyle W, Denver AE, et al: The relationship of urinary albumin excretion rate to ambulatory blood pressure and erythrocyte sodium-lithium countertransport in NIDDM. Diabetologia 38:356-362, 1995
22. Gould MM, Mohamed-Ali V, Goubet SA, et al: Microalbuminuria: Associations with height and sex in non-diabetic subjects. Br Med J 306:240-242, 1993
23. Chesham J, Anderton SW, Kingdon CFN: Rapid competitive enzymoimmunoassay for albumin in urine. Clin Chem 32:666-671, 1986
24. Mohamed-Ali V, Yudkin JS: An endpoint amplified immunoenzymometric assay (IEMA) for insulin. Clin Sci 82:127, 1992 (abstr)
25. + countertransport by physiological levels of insulin in vitro. J Hypertens 9:713-717, 1991
26. Mangili R, Bending JJ, Scott G, et al: Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy. N Engl J Med 318:146-150, 1988
27. Halkin A, Benjamin N, Doktor HS, et al: Vascular responsiveness and cation exchange in insulin dependent diabetes. Clin Sci 81:223-232, 1991
28. Ng LL, Bomford J: Altered stoichiometry of the human leucocyte Na/H antiport with decreasing pH. Biochem J 259:311-314, 1989
29. Morgan DB, Stewart AD, Davidson C: Relations between erythrocyte lithium afflux, blood pressure and family histories of hypertension and cardiovascular disease: Studies in a factory workforce and hypertension clinic. J Hypertens 4:609-615, 1986
30. Siebers RW, Mailing TJ: Kinetics of sodium-lithium counter-transport in normotensive and hypertensive subjects. J Cardiovasc Pharmacol 16:559-561, 1990 (suppl 7)
31. Trevisan M, Vaccaro O, Laurenzi M, et al: Hypertension, non-insulin dependent diabetes and intracellular sodium metabolism. Hypertension 11:264-268, 1988
32. Nosadini R, Cipollina MR, Solini A, et al: Close relationships between microalbuminuria and insulin resistance in essential hypertension and non-insulin dependent diabetes mellitus. J Am Soc Nephrol 2:S56-S63, 1992
33. Herman WH, Prior DE, Yassine MD, et al: Nephropathy in NIDDM is associated with cellular markers for hypertension. Diabetes Care 16:815-818, 1993
34. Sampson MJ, Denver E, Foyle WJ, et al: Association between left ventricular hypertrophy and erythrocyte sodium lithium exchange in normotensive subjects with and without NIDDM. Diabetologia 38:454-460, 1995
35. Laurenzi M, Trevisan M: Sodium-lithium countertransport and blood pressure. The Gubbio population study. Hypertension 13:408-415, 1989
36. Armitage P, Berry G: Statistical Methods in Medical Research, Oxford, UK, Blackwell Scientific, 1991, p 181
37. Zaidi KF, Yudkin JS: Characteristics of the sodium/ hydrogen exchange in non-insulin-dependent diabetic patients with microalbuminuria and hypertension. Clin Sci 90:13-19, 1996
38. Canessa M, Morgan K, Goldszer R, et al: Kinetic abnormalities of the red blood cell sodium-proton exchange in hypertensive patients. Hypertension 17:340-348, 1991
39. Rutherford PA, Thomas TH, Wilkinson R: Erythrocyte sodium-lithium countertransport: Clinically useful, pathophysiologically instructive or just phenomenology? Clin Sci 82:341-352, 1992